
    
      This is a multi-center, prospective, open, observational and optimal clinical research to
      evaluate the clinical effectiveness and safety of different doses of micafungin sodium for
      injection in patients with hematological tumors. Researchers screened suitable subjects
      according to the admission criteria, and after signing the informed consent form, micafungin
      sodium for injection was used for preventive or empirical treatment. During the treatment
      period, subjects who need to change the treatment plan due to uncontrollable infection or
      other reasons will withdraw from this research and the researchers will decide the follow-up
      treatment plan.All subjects were monitored for efficacy and safety according to the visit
      plan during the research.
    
  